Rosuvastatin Again Linked With Risks to Kidneys - Medscape

Practice should more often heed FDA-recommended rosuvastatin dosages for patients with severe chronic kidney disease and step up monitoring for renal safety in such cases, experts say.

Rosuvastatin for cholesterol lowering was associated with slightly greater risks for kidney harm than atorvastatin, risks that were greater at higher-dose levels, in a large retrospective cohort stud… [+6827 chars]

full article...